US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021) - Daedal Research - PowerPoint PPT Presentation

Loading...

PPT – US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021) - Daedal Research PowerPoint presentation | free to download - id: 837b4c-MzlmN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021) - Daedal Research

Description:

The report entitled “US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the US DESS market – PowerPoint PPT presentation

Number of Views:11

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2016-2021) - Daedal Research


1
US Drug Eluting Sinus Stent (DESS) Market Size,
Trends Forecasts (2016-2021)
September 2016
2
US Drug Eluting Sinus Stent Market Report
Scope of the Report The report entitled US Drug
Eluting Sinus Stent (DESS) Market Size, Trends
Forecasts (2016-2021), provides analysis of the
US DESS market, with detailed analysis of market
size and growth, penetration, market share and
economic impact of the industry. The analysis
includes the market by value (TAM), by volume and
by utilization. The report also provides the
analysis of the US sinus surgery market,
including analysis of FESS market and BSD
market. Furthermore, the report also assesses the
key opportunities in the market and outlines the
factors that are and will be driving the growth
of the industry. Growth of the overall US DESS
market has also been forecasted for the years
2016-2021, taking into consideration the growth
pattern of sinus surgery market, the growth
drivers and the current and future trends.
Intersect is the only company manufacturing drug
eluting sinus stents, but the competitive
landscape of the market includes other indirect
competitors, such as Medtronic, Entellus Medical
and Acclarent (JJ), whose company profiling has
been done in the report. In this segment of the
report, business overview, financial overview and
business strategies of the companies are
provided. Company Coverage Intersect
ENT Medtronic (Xomed) Entellus Medical Acclarent
(JJ)
3
US Drug Eluting Sinus Stent Market Report
Executive Summary Sinuses are the hollow cavities
located in the bones of the face and around the
nose. There are four sinus cavities frontal,
maxillary, ethmoid, and sphenoid, each with
different features. Under normal conditions, the
secretion (mucous) flow through the nasal
passages, but with the onset of sinusitis, the
secretion gets blocked in the sinuses due to
inflammation. Sinusitis disturbs the normal
lifestyle of a person and sometimes become
frustrating, as it affects the persons
breathing, sleeping and eating. Sinusitis can be
divided into Acute Sinusitis, Recurrent Acute
Rhinosinusitis (RARS) and chronic Rhinosinusitis
(CRS), on the basis of the duration of the
episode of sinusitis and its severity. The
treatment options for the sinusitis can be
over-the-counter treatment, medical management
and surgery. The OTC treatment includes
decongestants, antihistamines, pain relievers and
nasal irrigation. Medical management includes
antibiotics and oral and nasal steroids. The
sinus surgeries are mainly of two types
Functional Endoscopic Sinus Surgery (FESS) and
Balloon Sinus Dilation (BSD). Intersect, is the
only company that has developed drug releasing
bio-absorbable implants (drug eluting sinus
stents- DESS) that enable targeted and sustained
release of therapeutic agents, increasing the
effectiveness of the sinus surgery. The US DESS
market is expected to increase at a significant
growth rate during the forecasted period
(2016-2021). The US DESS market is supported by
various growth drivers, such as limitations of
FESS treatment, benefits of DESS, increasing per
capita healthcare expenditure, cost effectiveness
of DESS, etc. Yet, the market faces certain
challenges, such as, reimbursement issues,
dependability on individual physicians
experience, limited trials after BSD, etc.
4
The number of sinusitis patients is expected to
increase at a CAGR of over the years
2016-2021. The number of sinusitis patients were
thousand in 2015, which is estimated to
increase to . thousand in 2021. Out of total
thousand ENT eligible patients in 2015, .
thousand patients were treated from medical
management and rest from surgery. The total
number of sinus surgery procedures have increased
to thousand and is expected to .
US Sinus Surgery Market Overview
  • US Sinus Surgery Market by Patient Segmentation
    2015-2021 (000)
  • US Sinus Surgery Market by Number of Sinus
    Patients 2015-2021 (000)
  • US Sinus Surgery Market by Number of Procedures
    2015-2021 (000)

5
US Sinus Surgery Market Segments Overview
  • US BSD Market by Number of Procedures 2015-2021
    (000)

US FESS Market by Number of Procedures
2015-2021 (000)
The number of FESS procedures was . thousand in
2015. The FESS procedures are expected to
increase at a CAGR of over the years
2016-2021, to reach thousand in 2021. The
number of procedures for balloon sinus dilation
was . thousand in 2015. The number of BSD
procedure is expected to increase at a CAGR of
over the years 2016-2021 to reach . thousand in
2021.
6
US Drug Eluting Sinus Stent (DESS) Market Overview
US DESS Market by TAM 2015-2021 (US Million)
US DESS Market by ASP and Utilization 2015-2021
US PROPEL Market by Units Sold and Number of
Procedure 2015-2018
The total addressable market for drug eluting
sinus stent (DESS) market was US.... million in
2015, assuming that The total addressable
market is expected to increase to US... in
2021, . implants per procedure were utilized in
2015, increasing (expected) to by 2017 with ..
The ASP of the DESS was US... in 2015 and is
expected to increase to US... in 2016. the
number of PROPEL units sold were in 2015 and
number of procedures in which PROPEL was used
were
7
Title US Drug Eluting Sinus Stent (DESS) Market
Size, Trends Forecasts (2016-2021) Published
Sep 2016 Pages 45 Price US 900 (Single-User
License) US 1800 (Corporate
License) For more Info http//www.daedal-researc
h.com//us-drug-eluting-sinus-stent-dess-market-siz
e-trends-forecasts-2016-2021
For more details please contact Mr. Rajeev Kumar
Tel 91-120-4553017 (9.30 am - 6.30 pm)
ISTMobile 91-8743975789 (24 X7)Enquiries
info_at_daedal-research.com
Daedal Research Daedal Research is a research and
consulting firm specialized in providing research
reports and customized business research and
analysis. The research firm offers a blend of the
best strategic consulting and market research
solutions, which promise data rich, cost
effective, and highly insightful analysis to help
its clients with perfect answers to their
important business queries.
About PowerShow.com